Benadryl Introduces New Controlled Coma Pills To Sedate Users For Entirety Of Allergy Season
May 21, 2020•6 min•Season 1Ep. 77
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Following today’s FDA approval for over-the-counter use, Benadryl’s new Sedate Plus could soon be alleviating your symptoms by forcing you into a deep state of unconsciousness for six months of allergy season.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast